Table 7.
Group | ALT (U/L) | AST (U/L) | T-BIL (μmol/L) |
---|---|---|---|
C | 49.40 ± 6.33 | 329.85 ± 68.82 | 0.83 ± 0.27 |
M | 50.72 ± 13.71 | 348.69 ± 93.96 | 0.80 ± 0.37 |
A | 52.08 ± 13.75 | 318.84 ± 50.50 | 0.88 ± 0.47 |
PF-1 | 56.82 ± 11.90 | 329.80 ± 74.53 | 0.89 ± 0.25 |
PF-2 | 50.92 ± 14.62 | 353.00 ± 57.18 | 0.87 ± 0.23 |
PF-3 | 52.00 ± 12.35 | 326.63 ± 87.02 | 0.92 ± 0.29 |
PF-4 | 50.60 ± 15.78 | 317.38 ± 76.14 | 0.92 ± 0.47 |
C, control; M, model; A, allopurinol; PF-1, combination 1; PF-2, combination 2; PF-3, combination 3; PF-4, combination 4; ALT, alanine aminotransferase; AST, aspartate aminotransferase; T-BIL, total bilirubin.